Search Results 331-340 of 14123 for 78%

  1. Publications - Scott W. Young, M.D. - Mayo Clinic

    2016 Jun; 41 (6):1066-78. View PubMed; Kriegshauser JS, Patel MD, Young SW, Chen F, Eversman WG, Chang YH, Smith M. Factors Contributing to the Success of ...

  2. Medical Research & Education - Mayo Clinic News Network

    76 · 77 · 78 ... Next · Last · Sign up to receive email notifications. Explore more topics. Scroll backwards. Biotherapeutics · Clinical Trials · Discovery ...

  3. Academics - Find a Program at Mayo Clinic College of Medicine & Science

    Search the more than 400 medical, surgical, health sciences, and biomedical research training programs at Mayo Clinic College of Medicine and Science.

  4. Low hemoglobin count Causes - Mayo Clinic

    A low hemoglobin count is a commonly seen blood test result. Hemoglobin (Hb or Hgb) is a protein in red blood cells that carries oxygen throughout the body.

  5. Hair loss - Doctors and departments - Mayo Clinic

    Capecitabine side effects are really tough: What helps? 8 Replies Sat, Mar 21, 2026. needshope78 · Need hope: Neuropathy from chemo. 168 Replies Fri, Mar 20 ...

  6. Medical Research & Education - Mayo Clinic News Network

    77 · 78 · 79 ... Next · Last · Sign up to receive email notifications. Explore more topics. Scroll backwards. Biotherapeutics · Clinical Trials · Discovery ...

  7. Medical Research & Education - Mayo Clinic News Network

    78 · 79 · 80 · 81 · 82 · 83 ... Next · Last · Sign up to receive email notifications. Explore more topics. Scroll backwards. Biotherapeutics · Clinical Trials ...

  8. Health Topics - Mayo Clinic News Network

    78 · 79 · 80 ... Next · Last. Explore more topics. Scroll backwards. Biotherapeutics · Clinical Trials · Discovery Science · Healthcare Delivery ...

  9. Medical Research & Education - Mayo Clinic News Network

    78 · 79 · 80 ... Next · Last · Sign up to receive email notifications. Explore more topics. Scroll backwards. Biotherapeutics · Clinical Trials · Discovery ...

  10. A Study to Evaluate the Safety and Effectiveness of BMS-986036 (pegbelfermin) in Adults with Nonalcoholic Steatophepatitis (NASH) and Compensated Liver Fibrosis - Mayo Clinic

    About this study. The purpose of this study is to confirm and extend the results observed in the Phase 1 and 2a studies with BMS-986036.